Sign in

CIK 0001896212

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
873272543
Phone
+1 646-491-9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-19 Bligh James CFO Grant or award +480,000 480,024
2024-11-18 Bligh James Interim CFO Grant or award · Stock Option (Right to Buy) +1,890,000 $0.09 $174K 1,890,000
2024-06-11 Bligh James Interim CFO Grant or award +37,272 37,272
2023-12-01 Bligh James Director Grant or award · Stock Option (Right to Buy) +223,634 $5.51 $1.2M 223,634

Page 1 of 1 · 4 trades